Biotech · Private company
jCyte, Inc
Track this companyFree. Adds jCyte, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- human retinal progenitor cellsPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
- human retinal progenitor cellsPhase 2 · Retinitis Pigmentosa (RP)ClinicalTrials.gov · fetched Nov 12, 2026
- Mock injectionPhase 2 · Retinitis PigmentosaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Safety of a Single, Intravitreal Injection of 6.0M jCell (Famzeretcel) in Retinitis Pigmentosa (RP)PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 20, 2025ClinicalTrials.gov NCT06912633 · fetched Nov 12, 2026
- Safety of Repeat Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis PigmentosaPHASE2 · COMPLETED · started Dec 1, 2020ClinicalTrials.gov NCT04604899 · fetched Nov 12, 2026
- Safety and Efficacy of Intravitreal Injection of Human Retinal Progenitor Cells in Adults With Retinitis PigmentosaPHASE2 · COMPLETED · started Mar 1, 2017ClinicalTrials.gov NCT03073733 · fetched Nov 12, 2026
- Safety of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Retinitis PigmentosaPHASE1_PHASE2 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02320812 · fetched Nov 12, 2026